Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus

Prevalence of Hepatitis E Virus and Its Associated Outcomes among Pregnant Women in China

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency

Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection

Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity

Urine is a viral antigen reservoir in hepatitis E virus infection

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2